Role of interferon in clinical practice

L. Sreter, J. Feher

Research output: Review article


Interferons are currently the most widely used biological response modifiers. They are of high clinical value in haematological malignancies (chronic myelogenous leukaemia, multiple myeloma, non-Hodgkin lymphoma), in solid tumours (malignant melanoma, hypernephroma, pancreas neoplasms, carcinoid tumours, Kaposi's sarcoma, glioma, in ovarium, cervix and bladder carcinoma, and in basalioma) an in infectious diseases (chronic hepatitis B, chronic non-A/non-B hepatitis, chronic delta hepatitis, AIDS, Papova virus and Rhinovirus infections, leishmaniasis, leprosy) and some other conditions. Although the mechanism of action of interfersons has not been explained in every detail these agents are promising therapeutic means in a number of diseases.

Original languageEnglish
Pages (from-to)159-166
Number of pages8
JournalTherapia Hungarica
Issue number4
Publication statusPublished - dec. 1 1991


ASJC Scopus subject areas

  • Medicine(all)

Cite this